Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects

NCT01165450 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped Drug manufacturer could not supply study drug.

Conditions

Interventions

Sponsor

University of California, San Francisco

Collaborators